Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Epoxide hydrolase.php on line 2
Epoxide hydrolase
LE WE PMID CA
Epoxide hydrolase3891Epoxid Hydrolase

Antiinflammatory compounds

Arterial hypertension (BASKET)

Atherosclerosis (BASKET)

CYP2C

CYP2J

Cytochrome P450 epoxygenase

Dihydroxyeicosatrienoic acid

Ephx2

Epoxide hydrolase

Epoxyeicosatrienoic acid EET

2006  
1
Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
[16961727] Cardiovasc Drug Rev 24(2): 169-88 (2006)
2009  
2
Arachidonic acid cytochrome P450 epoxygenase pathway.
[18952572] J Lipid Res 50 Suppl(-): S52-6 (2009)
2010  
3
Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
[19891972] J Mol Cell Cardiol 48(2): 331-41 (2010)
2010  
4
Targeting epoxides for organ damage in hypertension.
[20531214] J Cardiovasc Pharmacol 56(4): 329-35 (2010)
2010  
5
Soluble epoxide hydrolase in atherosclerosis.
[20425256] Curr Atheroscler Rep 12(3): 174-83 (2010)
2007  
6
Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).
[17164131] Prostaglandins Other Lipid Mediat 82(1-4): 42-9 (2007)
PMC   
7
Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.
[23176298] Br J Pharmacol 168(8):1794-807 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Epoxide hydrolase.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Epoxide hydrolase.php on line 92